Literature DB >> 22055939

Expression analysis of ADAM17 during mouse eye development.

Saadettin Sel1, Thomas Kalinski, Isabelle Enssen, Maja Kaiser, Norbert Nass, Stefanie Trau, Gregor Wollensak, Lars Bräuer, Kristin Jäger, Friedrich Paulsen.   

Abstract

ADAM17 (a disintegrin and metallopeptidase domain 17) is crucial for eye morphogenesis. In this study we analysed the expression pattern of ADAM17 during mouse eye development. ADAM17 expression in adult retina was examined using the reverse transcription-polymerase chain reaction (RT-PCR) and verification of the RT-PCR products by DNA sequencing. Immunohistochemistry was performed to evaluate the ADAM17 expression pattern in mouse eyes at developmental stages of embryonic day (E) 12, E14, E16, E18, postnatal day (P) 0, P1, P4, P7, P14, P 30 and P175 (adult). We detected ADAM17 mRNA in adult retina tissue. ADAM17 protein was expressed in non-pigmented ciliary epithelial cells and in retinal vessels from P7 onwards during eye development. In corneal epithelial cells and endothelium, ADAM17 protein was present from P14 onwards. Although, mice in which the functional ADAM17 gene is significantly reduced develop multiple eye malformations, the expression of ADAM17 is not ubiquitous over the entire eye. Its expression pattern during development suggests that not only TNF-alpha but additional membrane-anchored substrates of ADAM17 play an important role in eye formation.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055939     DOI: 10.1016/j.aanat.2011.10.008

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  5 in total

1.  Anatomical and Gene Expression Changes in the Retinal Pigmented Epithelium Atrophy 1 (rpea1) Mouse: A Potential Model of Serous Retinal Detachment.

Authors:  Gabriel Luna; Geoffrey P Lewis; Kenneth A Linberg; Bo Chang; Quiri Hu; Peter J Munson; Arvydas Maminishkis; Sheldon S Miller; Steven K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-09-01       Impact factor: 4.799

2.  Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway.

Authors:  Daejin Kim; Hyun-Suk Ko; Ga Bin Park; Dae Young Hur; Yeong Seok Kim; Jae Wook Yang
Journal:  Exp Ther Med       Date:  2017-02-08       Impact factor: 2.447

3.  Titanium dioxide nanoparticles impair the inner blood-retinal barrier and retinal electrophysiology through rapid ADAM17 activation and claudin-5 degradation.

Authors:  Yen-Ju Chan; Po-Lin Liao; Chi-Hao Tsai; Yu-Wen Cheng; Fan-Li Lin; Jau-Der Ho; Ching-Yi Chen; Ching-Hao Li
Journal:  Part Fibre Toxicol       Date:  2021-01-09       Impact factor: 9.400

Review 4.  The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.

Authors:  Koji Kitazawa; Stefanie Deinhardt-Emmer; Takenori Inomata; Sharvari Deshpande; Chie Sotozono
Journal:  Cells       Date:  2021-04-02       Impact factor: 6.600

5.  A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development.

Authors:  Joseph A Toonen; Adam Ronchetti; D J Sidjanin
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.